Bupivacaine Extended-Release Liposome Injection Exhibits a Favorable Cardiac Safety Profile

Sergio D. Bergese; Erol Onel; Michael Morren; Joel Morganroth

doi:10.1097/aap.0b013e31823d0a80

Bupivacaine Extended-Release Liposome Injection Exhibits a Favorable Cardiac Safety Profile

Regional Anesthesia and Pain Medicine ◽

10.1097/aap.0b013e31823d0a80 ◽

2012 ◽

Vol 37 (2) ◽

pp. 145-151 ◽

Cited By ~ 39

Author(s):

Sergio D. Bergese ◽

Erol Onel ◽

Michael Morren ◽

Joel Morganroth

Keyword(s):

Safety Profile ◽

Extended Release ◽

Cardiac Safety

Download Full-text

8-week Safety Profile of Tapentadol Extended Release Tablets Switched from Other Opioids for Well-controlled, Moderate to Severe, Chronic Malignant Tumor-related Pain: Constipation, Nausea, Vomiting and Somnolence

Palliative Care Research ◽

10.2512/jspm.11.116 ◽

2016 ◽

Vol 11 (1) ◽

pp. 116-122

Author(s):

Keiichiro Imanaka ◽

Takashi Yoshimura ◽

Yushin Tominaga ◽

Hiromi Koga ◽

Keiichiro Hirose

Keyword(s):

Malignant Tumor ◽

Safety Profile ◽

Extended Release

Download Full-text

Cardiac safety profile of trastuzumab in elderly patients

Journal of Geriatric Oncology ◽

10.1016/j.jgo.2013.09.022 ◽

2013 ◽

Vol 4 ◽

pp. S32-S33

Author(s):

T. Silovski ◽

L. Vazdar ◽

R. Šeparović ◽

M. Pavlovic

Keyword(s):

Elderly Patients ◽

Safety Profile ◽

Cardiac Safety

Download Full-text

Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-017-3420-8 ◽

2017 ◽

Vol 80 (4) ◽

pp. 787-798 ◽

Cited By ~ 18

Author(s):

Keith M. Skubitz ◽

Anne H. Blaes ◽

Suma H. Konety ◽

Gary S. Francis

Keyword(s):

Left Ventricular Ejection Fraction ◽

Ejection Fraction ◽

Safety Profile ◽

Liposomal Doxorubicin ◽

Pegylated Liposomal Doxorubicin ◽

Left Ventricular ◽

Ventricular Ejection ◽

Left Ventricular Ejection ◽

Cardiac Safety ◽

Ventricular Ejection Fraction

Download Full-text

31.8 REAL-WORLD SAFETY PROFILE OF DELAYED-RELEASE AND EXTENDED-RELEASE METHYLPHENIDATE FOR ADHD IN CHILDREN, ADOLESCENTS, AND ADULTS

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2020.08.279 ◽

2020 ◽

Vol 59 (10) ◽

pp. S213

Author(s):

Ann Catherine Childress ◽

Victor Otcheretko ◽

Lewis E. Warrington ◽

Justin A. Barnes ◽

Ryan A. Gregg ◽

...

Keyword(s):

Real World ◽

Safety Profile ◽

Extended Release ◽

Delayed Release ◽

Adolescents And Adults

Download Full-text

The arrhythmogenic potential of nerve agents and a cardiac safety profile of antidotes - A proof-of-concept study using human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CM)

Toxicology Letters ◽

10.1016/j.toxlet.2019.03.003 ◽

2019 ◽

Vol 308 ◽

pp. 1-6 ◽

Cited By ~ 4

Author(s):

Niko Amend ◽

Horst Thiermann ◽

Franz Worek ◽

Timo Wille

Keyword(s):

Stem Cells ◽

Induced Pluripotent Stem Cells ◽

Pluripotent Stem Cells ◽

Safety Profile ◽

Nerve Agents ◽

Proof Of Concept ◽

Cardiac Safety ◽

Concept Study ◽

Arrhythmogenic Potential ◽

Induced Pluripotent

Download Full-text

P148 LACK OF INFLUENCE OF ELDERLY AGE AND GENDER ON THE SAFETY PROFILE OF BUDESONIDE EXTENDED-RELEASE TABLETS FOR ULCERATIVE COLITIS: A POOLED ANALYSIS OF TWO RANDOMIZED, DOUBLE-BLIND, PHASE 3 TRIALS

Gastroenterology ◽

10.1053/j.gastro.2017.11.197 ◽

2018 ◽

Vol 154 (1) ◽

pp. S78

Author(s):

Gary R. Lichtenstein ◽

Zeev Heimanson ◽

Brian P. Bosworth

Keyword(s):

Ulcerative Colitis ◽

Safety Profile ◽

Extended Release ◽

Pooled Analysis ◽

Elderly Age ◽

Phase 3 ◽

Double Blind ◽

Age And Gender ◽

And Gender

Download Full-text

Cardiac Safety Profile of Nebulized Formoterol in Adults with COPD: A 12-Week, Multicenter, Randomized, Double- Blind, Double-Dummy, Placebo- and Active-Controlled Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2007.10.007 ◽

2007 ◽

Vol 29 (10) ◽

pp. 2167-2178 ◽

Cited By ~ 21

Author(s):

Harold S. Nelson ◽

Nicholas J. Gross ◽

Bernard Levine ◽

Edward M. Kerwin ◽

Mike Rinehart ◽

...

Keyword(s):

Safety Profile ◽

Controlled Trial ◽

Cardiac Safety ◽

Double Blind

Download Full-text

Safety Profile of Extended-Release Niacin in the AIM-HIGH Trial

New England Journal of Medicine ◽

10.1056/nejmc1311039 ◽

2014 ◽

Vol 371 (3) ◽

pp. 288-290 ◽

Cited By ~ 51

Author(s):

Todd J. Anderson ◽

William E. Boden ◽

Patrice Desvigne-Nickens ◽

Jerome L. Fleg ◽

Moti L. Kashyap ◽

...

Keyword(s):

Safety Profile ◽

Extended Release

Download Full-text

Cardiac safety profile of etamicastat, a novel peripheral selective dopamine-β-hydroxylase inhibitor in non-human primates, human young and elderly healthy volunteers and hypertensive patients

IJC Metabolic & Endocrine ◽

10.1016/j.ijcme.2015.03.002 ◽

2015 ◽

Vol 7 ◽

pp. 10-24 ◽

Cited By ~ 3

Author(s):

Manuel Vaz-da-Silva ◽

José-Francisco Rocha ◽

Pierre Lacroix ◽

Amílcar Falcão ◽

Luís Almeida ◽

...

Keyword(s):

Healthy Volunteers ◽

Safety Profile ◽

Cardiac Safety ◽

Hypertensive Patients ◽

Selective Dopamine

Download Full-text

Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States

Drug Healthcare and Patient Safety ◽

10.2147/dhps.s97113 ◽

2015 ◽

pp. 169 ◽

Cited By ~ 5

Author(s):

Michele Jara ◽

Thomas Aquilina ◽

Peter Aupperle ◽

Adrian Rabinowicz

Keyword(s):

United States ◽

Multiple Sclerosis ◽

Safety Profile ◽

Extended Release ◽

The United States

Download Full-text